Zacks.com on MSN

Why Is CRISPR Therapeutics (CRSP) Up 3.3% Since Last Earnings Report?

CRISPR Therapeutics (CRSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health

Detailed price information for Myriad Genetics Inc (MYGN-Q) from The Globe and Mail including charting and trades.

Is CRISPR (CRSP) Using CTX310 To Quietly Redefine Its Rare-Disease-Centric Investment Story?

CRISPR Therapeutics recently drew attention as updates highlighted progress in its gene-editing pipeline, including early-stage studies of CTX310, an in vivo therapy designed to lower LDL cholesterol ...

Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet?

Detailed price information for Krystal Biotech Inc (KRYS-Q) from The Globe and Mail including charting and trades.